Peptide
Reference library
Educational peptide reference — research use only.
Research & educational use only
For laboratory and educational research only. Not for human or veterinary consumption. This is not medical advice. Always follow applicable laws and consult qualified professionals.
The calculator performs unit math for research reference. It must not be used to plan or guide dosing in humans or animals. Verify all figures independently in your lab protocol.
Tesamorelin + Ipamorelin Mix
A GH-axis blend pairing Tesamorelin with Ipamorelin in metabolic research.
- Half-life (approx.)
- Mixed — GHRH + GHRP kinetics (approx.)
- Diluent
- Bacteriostatic water (0.9% benzyl alcohol)
- Common vials
- 5, 10 mg
Half-life figures are literature approximations for educational reference — not pharmacokinetic advice.
Overview
This blend pairs tesamorelin with ipamorelin for GH-axis research combining GHRH stimulation with selective GHRP activity. As with all blends, confirm per-peptide milligrams on the label before using the reconstitution calculator. GHRH (tesamorelin) + GHRP (ipamorelin) dual stimulation blend for GH-axis research.
Structure & identity
Blend: Tesamorelin + ipamorelin
- Sequence / structure
- Blend: Tesamorelin + ipamorelin
Mechanism
Tesamorelin (GHRH) + ipamorelin (GHRP) for dual GH-axis stimulation. Stabilized GHRH pharmacology paired with selective GHRP — alternative to CJC+IPA combination.
Studies & clinical programs
GH-axis dual stimulation research
Published research models
- Peer-reviewed literature documents endpoints under GH-axis dual stimulation research experimental designs.
Research models in literature
- GH-axis dual stimulation research
Literature highlights
- Tesamorelin (GHRH) plus ipamorelin (GHRP) for dual GH-axis stimulation in research models.
- Compared with CJC+IPA blends — tesamorelin brings stabilized GHRH pharmacology.
- GH and IGF-1 endpoints measured in combination stimulation studies.
Combination research notes
GHRH + GHRP class combination.
Key targets & pathways
Research areas
Routes in research literature
Blend components
Also known as
Stability & storage phases
| Phase | Condition | Guidance |
|---|---|---|
| Lyophilized blend | Refrigerated (2–8 °C), sealed | Confirm per-peptide mg breakdown on analytical documentation before storage; blended cakes may dissolve more slowly than single-peptide vials. |
| Reconstituted | Bacteriostatic water, refrigerated | Gently swirl until all components dissolve; stability limited by the most labile peptide in the mixture — label total and per-component concentration. |
| Working aliquots | Frozen (−20 °C) aliquots with component ratio noted | Calculate per-peptide exposure from verified blend ratios only; do not assume equal mg across components without analytical composition verification. |
Stability windows are formulation-dependent — verify published data and your lab SOP.
Reconstitution reference table
| Vial (mg) | Diluent (mL) | mcg/mL | Units @ 100 mcg | Units @ 250 mcg | Units @ 500 mcg |
|---|---|---|---|---|---|
| 5 | 2 | 2500.0 | 4 | 10 | 20 |
| 10 | 2 | 5000.0 | 2 | 5 | 10 |
U-100 insulin syringe scale (100 units = 1 mL). Illustrative only — not dosing guidance.
Reconstitution steps
- Confirm per-peptide composition from analytical documentation before any calculations
- Allow vial to reach room temperature (15–30 min)
- Swab stopper; inject diluent slowly down vial wall
- Gently swirl — blends may take longer to fully dissolve
- Label with date, total concentration, and component note
- Refrigerate; calculate per-peptide dose from verified ratios
Component ratios vary; confirm per-peptide mg in the blend before calculating.
Laboratory record checklist
- Compound identity recorded in lab notebook (name, lot, preparation date)
- Analytical identity cross-checked against published sequence or structure
- Potency or concentration documented from analytical certificate when available
- Purity or HPLC data filed when provided with research material
- Appearance noted: intact lyophilized cake or uniform powder
- Sterility / endotoxin report archived when available
- Storage temperature applied immediately per published stability guidance